Home / Contact / Sitemap / Disclaimer
ABOUT US
PERSONALIZED MEDICINE
& CNS
PRODUCTS & TECHNOLOGY
BUSINESS DEVELOPMENT
MEDIA
   
Key Concepts
PsychINDxTM
Homomatrix®
Drug Development
Glossary
 
 

As the regulatory agencies and pharmaco-economic pressures increasingly call for more effective drugs, we believe that personalized or targeted medicines represent the next generation of pharmaceutical treatment.

At Curidium, we have set out to fully exploit our PsychINDx™ diagnostic tool and core Homomatrix® technology to develop, in partnership with pharmaceutical and biotechnology companies, targeted medicines for specific patient subgroups for a range of heterogeneous human diseases, including schizophrenia and bipolar disorder.

Curidium Ltd. © 2006-2009 | Email: info@curidium.com Tel.: +44 (0)20 7554 5100
This site was last updated on 05.03.09